Bifidobacterium and Lactobacillus improve inflammatory bowel disease in zebrafish of different ages by regulating the intestinal mucosal barrier and microbiota

Y Ni, Y Zhang, L Zheng, N Rong, Y Yang, P Gong… - Life Sciences, 2023 - Elsevier
Aims Inflammatory bowel disease (IBD) patients are accompanied by impaired intestinal
barrier integrity and gut microbiota dysbiosis. Strategies targeting the gut microbiota are …
被引用次数：25 相关文章

Bifidobacterium and Lactobacillus improve inflammatory bowel disease in zebrafish of different ages by regulating the intestinal mucosal barrier and microbiota.

Y Ni, Y Zhang, L Zheng, N Rong, Y Yang, P Gong… - Life …, 2023 - europepmc.org
Inflammatory bowel disease (IBD) patients are accompanied by impaired intestinal barrier
integrity and gut microbiota dysbiosis. Strategies targeting the gut microbiota are potential …

[引用][C] Bifidobacterium and Lactobacillus improve inflammatory bowel disease in zebrafish of different ages by regulating the intestinal mucosal barrier and microbiota

Y Ni, Y Zhang, L Zheng, N Rong, Y Yang, P Gong… - Life Sciences, 2023 - cir.nii.ac.jp
Bifidobacterium and Lactobacillus improve inflammatory bowel disease in zebrafish of different
ages by regulating the intestinal mucosal barrier and microbiota | CiNii Research CiNii 国立 …

Bifidobacterium and Lactobacillus improve inflammatory bowel disease in zebrafish of different ages by regulating the intestinal mucosal barrier and microbiota

Y Ni, Y Zhang, L Zheng, N Rong, Y Yang… - Life …, 2023 - pubmed.ncbi.nlm.nih.gov
Aims Inflammatory bowel disease (IBD) patients are accompanied by impaired intestinal
barrier integrity and gut microbiota dysbiosis. Strategies targeting the gut microbiota are …